Skip to content
NNeuroBrief

Independent briefing · Primary sources re-checked

The papers worth your time, checked against the source.

NeuroBrief is for neurologists, neuroscientists, and the clinicians beside them. We gather the new literature, re-check the claims against the primary paper, and write what actually changed — including what the study does not show.

Twice a week. One price. Cancel any time. Not medical advice.

Example · not a real study

Dementia · Verified 12 November 2026

A fictional plasma panel and amyloid PET

The claim, the cohort, and the limit of the result — written so you can decide whether the paper is worth opening. The study described in the sample does not exist.

Open the sample

Re-checked
Claims are compared with the primary paper, preprint, or official notice.
Signed
Every briefing carries a verification status and the date an editor signed.
$10/month
Full text and sources. Headlines stay open. The rest is the subscription.

Demo archive

Sample briefings

Open the archive

Each of these is an EXAMPLE. The format is the product. The studies are not real and should not be cited.

Method

Curation is not the same thing as verification.

01

Gather

New papers, journal issues, and public notices go into a review queue. PubMed and a few journal feeds can be pulled in for an editor. Nothing in that queue is published.

02

Re-check

An editor opens the primary paper, preprint, or official notice and compares the claim with what the source actually reports: cohort, endpoint, numbers, and the limit of the result.

03

Sign

The briefing names its sources and the date it was verified. If the source is later corrected, the piece is updated and marked corrected. Pending means it is not signed.

What verification means here

  • The claim matches the source’s own conclusion
  • Population, sample size, and endpoint are stated
  • An effect is not rewritten as clinical advice
  • Funding and conflicts are noted when the source states them
  • Preprints, corrections, and retractions stay labeled
  • The verified-on date is the day an editor signed, not the day a press release landed

Readers

Written for people who already read the literature.

Clinical neurologists

A short, sourced account of what changed, readable before clinic, with the caveat still attached.

Neuroscientists

Adjacent fields, without pretending a single paper settled them. Methods and limits stay in the piece.

Fellows and research staff

The citation, the endpoint, and what the study does not show — not a rewrite of the embargoed quote.

Pricing

One subscription. The whole briefing.

No seats, no annual upsell, no second tier. twice a week in the live service. Cancel whenever you like.

NeuroBrief

$10per month

  • Every published briefing, in full
  • Primary sources linked on each piece
  • Verification status and the date an editor signed
  • The archive of briefings published so far
  • A billing portal to update a card or cancel, once Stripe is connected
Subscribe — $10/month

Demo mode simulates the charge until Stripe keys are set. No card is collected here.

Questions

Before you subscribe

Read the next briefing with the sources attached.

$10/month. The sample archive is already loaded, and it is labeled as fiction.

Create an account